Programme faculty includes:
Mr. Jeremy Whitty – Programme Director
Dr. Jane Barrett
Dr. Marian Brennan
Dr. Dermot Cox
Dr. Anthony J. Chubb
Dr. Dolores Dooley
Dr. Tim Grant
Ms. Kathy Heard
Dr. Stephanie J. Jones
Prof. Brian S. Mandell
Mr. Carl Naraynassamy
Dr. Hugh O’Doherty
Dr. Eleanor O’Higgins
Ms. Mary Rafter
Prof. David Smith
Mr. Jeremy Whitty – Programme Director
Jeremy Whitty is the Programme Director of the M.Sc. in Pharmaceutical Medicine at the School of Health Sciences, Hibernia College, Dublin and is Professor of Operations and Quality in the Life Sciences at IE Business School, Madrid.
As well as extensive academic experience in the Life Sciences, Jeremy has over 17 years industrial experience working with such companies as Wyeth Biotech (now Pfizer), Medtronic and Bausch & Lomb. His research includes the application of best practices in decision engineering to drug development, especially from Proof of Concept to the end of Phase IIb. He is currently conducting doctoral research at Trinity College Dublin.
Dr. Jane Barrett, MBBS, FFPM, LLM qualified in medicine in 1976 and began work as a family doctor. In 1985 she joined the pharmaceutical industry, working for large and small pharmaceutical companies and then for a global Contract Research Organisation.
In 2001 she was awarded a Master’s degree (LLM) in Medical Law after a study sabbatical. She was particularly interested in the legal and ethical aspects of clinical research, and her dissertation was on the use of vulnerable patient groups in research.
Jane is the immediate past Chairman of the British Association of Pharmaceutical Physicians, and is Registrar of the Faculty of Pharmaceutical Medicine.
Dr. Barrett founded the Barrett Consultancy in 2001, and provides medical and legal expertise to pharmaceutical companies. She is also Consultant Medical Adviser and Director to MedicoLegal Investigations Ltd, a UK-based company investigating alleged fraud and misconduct in clinical research.
Dr. Marian Brennan completed her undergraduate degree in Medical Biochemistry at the University of Cape Town, South Africa, majoring in genetics and microbiology. She completed her Ph.D. at the Royal College of Surgeons in Ireland, investigating the mechanisms of interaction between Staphylococci and platelets. Current research is focussed on the development of novel drugs to treat the thrombotic events associated with staphylococcal infections, as well as novel anti-bacterial agents.
Dr. Dermot Cox is a lecturer in the School of Pharmacy in the Royal College of Surgeons in Ireland. His research interests include the role of infection in thrombosis and the clinical development of GPIIb/IIIa antagonists.
Dr. Anthony J. Chubb obtained his Ph.D. in 2002 at the University of Cape Town and is currently a postdoctoral fellow in the Department of Clinical Pharmacology at the Royal College of Surgeons in Ireland. Trained as a molecular biologist, his projects include isolation of novel surface proteins in mycobacterium tuberculosis, using mutagenesis to define the sheddase recognition site of ACE and the PGG2 binding site of COX, and the development of novel NSAID inhibitors of COX. His interests are in structural biology and drug design, especially pharmacophore-based chemoinformatics. Dr. Chubb is co-founder of the consultancy Molecular Biology Solutions Ireland Ltd.
Dr. Dolores Dooley lectures in philosophy and specialises in bioethics. Born in Chicago, Illinois, she received her Ph.D. in 1974 from the University of Notre Dame, USA. She taught in the US at Mundelein College, Chicago, and Notre Dame University before moving to Ireland.
Dr. Tim Grant is a graduate of the University of Wisconsin-Madison, where he studied Biostatistics (MS) and Educational Psychology (PhD). He is currently working as a biostatistician for the Centre for Support and Training of Analysis and Research (CSTAR) located in the School of Public Health, Physiotherapy and Population Sciences at University College Dublin. At the centre, Tim conducts consulting and short courses assisting biomedical researchers across Ireland improve the quality of their research. He is also a chartered statistician (CStat) and scientist (CSci) through the Royal Statistical Society. Tim has been involved in the research process using both qualitative and quantitative methods for over 15 years. In addition to his experience in biomedical research, he has conducted research in the fields of education, business and mechanical engineering.
Kathy Heard is a graduate of Hibernia College’s M.Sc. in Pharmaceutical Medicine and has a Bachelor of Commerce from McMaster (Canada). She has worked in the pharmaceutical industry for 15 years, starting in regulatory affairs with a small dental company. For the past 12 years, she has worked at sanofi pasteur in the clinical department located in Toronto, Canada. During her career at sanofi pasteur, she has been a clinical research associate (CRA), a trial manager, a project manager and a global trainer. Kathy has been responsible for trials conducted in Mexico, Canada, Australia, Brazil and the US, and has been a key contributor to Biologic Licensing Applications in the US and CTDs in Canada and Europe. Currently, her responsibilities include managing the study management platform, working with outsourcing partners and participating on oversight committees for ECD and IVRS.
Dr. Stephanie-Jayne Jones (BClinSci MBChB MRCP DipPharmMed) worked in the NHS for five years, gaining experience in psychiatry, A&E and paediatrics. She joined the pharmaceutical industry in 2001 and has worked in medical affairs and drug safety for a number of different companies, including Abbott Laboratories, GlaxoSmithKline and, more recently, a biotechnology company called Renovo. There, she managed the Medical Affairs and Pharmacovigilance department and was the sole company pharmaceutical physician. She now has a baby daughter and is working as a part-time GP registrar in Cheshire, but wishes to keep an interest in pharmaceutical medicine.
Prof. Brian S. Mandell is a senior lecturer in Public Policy and Director of the Negotiation Project at the Kennedy School Government at Harvard University. He is also Chair of the Wexner-Israel and Kokkalis Fellowship programmes at the school. His current teaching and research address the theory and practice of negotiation, emphasising third-party facilitation and consensus-building in domestic and international protracted policy disputes. He writes about contentious disputes and is completing a book on scenario planning for conflict managers and negotiation practitioners. Before coming to Harvard, Prof. Mandell taught at the Norman Paterson School of International Affairs at Carleton University in Ottawa. Previously, he was a strategic analyst for the Canadian Department of National Defense, specialising in UN peacekeeping and the implementation of arms control agreements. A Pew Faculty Fellow and Senior Research Associate at the Kennedy School’s Belfer Center for Science and International Affairs, Prof. Mandell holds a PhD from the University of Toronto.
Carl Naraynassamy MAEd (Brunel), LLB (Lond), BSc (Lond) is an independent consultant in education and training of clinical research and pharmaceutical medicine. His whole 29-year career has been spent working in training institutions or in the pharmaceutical industry, mostly in roles related to drug development. He specialises in the audits of professional education and the development of competency workshops.
Dr. Hugh O’Doherty teaches courses in leadership and conflict resolution. He has been program director at the Glencree Center for Peace and Reconciliation in Ireland, director of the Northern Ireland Inter-Group Relations Project, and director of the Ireland-U.S. Public Leadership Program at the James McGregor Burns Academy of Leadership, University of Maryland. Dr. O’Doherty has consulted on conflict resolution and leadership to a wide range of organisations in Ireland, the United States, Cyprus, and Canada.
Dr. Eleanor O’Higgins (BA, MSc, MBA, PhD) is on the faculty of the Business School at UCD and a visiting fellow at the London School of Economics and Political Science. She specialises in teaching, research and publications in business ethics, corporate governance, corporate social responsibility and strategic management.
She is a director of Transparency International Ireland and a member of the ethics committee of the US Academy of Management, the United Nations Global Compact Learning Forum, the Board of Management of the Institute of Directors’ Centre for Corporate Governance at University College Dublin and of the advisory board of Centro de Excelencia en Gobierno Corporativo (Centre of Excellence in Corporate Governance) in Mexico. She is also on the editorial boards of a number of international management journals.
Dr. O’Higgins carries out numerous teaching and speaking assignments internationally and has extensive experience in business through consulting work, her previous managerial career and as a company director.
Mary obtained a Bachelor of Science (Pharmacy) degree from University College Dublin in 1979 and registration as a qualified pharmacist (MPSI) in 1980. She has recently completed a Masters Degree in Pharmaceutical Medicine in Trinity College Dublin. For 14 years of her 30 year career Mary worked for the Irish Medicines Board (IMB), the regulatory body responsible for the licensing of medicines in Ireland. With the IMB she was a pharmaceutical assessor and represented the board on a number of EU Committees. Her roles in the IMB have alternated with periods in industry, where she held various positions, including Quality Assurance Manager, EU Qualified Person, and from 2004 to 2010 Senior Regulatory Affairs Manager for a global team based in Pfizer Newbridge, Ireland.
Prof. David Smith (B.Phil, B.D., S.T.L., M.A., S.T.D.) is director of the MSc in Healthcare Ethics and Law in the Royal College of Surgeons in Ireland (RCSI), visiting senior lecturer in Medical Ethics in the RCSI and invited senior lecturer in Trinity College Dublin, University College Dublin, University College Cork and the Church of Ireland Theological College. He is also actively involved as an ethics consultant with such groups as CIRCA Healthcare Consulting, the Haughton Institute, Bon Secours Health System, Sisters of Charity of Jesus and Mary Services, the Mercy University Hospital, KARE and the Daughters of Charity Services for People with Intellectual Disability.
